454 related articles for article (PubMed ID: 10328250)
1. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.
Kwon OJ; Karni A; Israel S; Brautbar C; Amar A; Meiner Z; Abramsky O; Karussis D
Arch Neurol; 1999 May; 56(5):555-60. PubMed ID: 10328250
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients.
Kwon OJ; Brautbar C; Weintrob N; Sprecher E; Saphirman C; Bloch K; Pinhas-Hamiel O; Assah S; Vardi P; Israel S
Hum Immunol; 2001 Jan; 62(1):85-91. PubMed ID: 11165718
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients.
Hodak E; Lapidoth M; Kohn K; David D; Brautbar B; Kfir K; Narinski N; Safirman S; Maron M; Klein K
Br J Dermatol; 2001 Dec; 145(6):974-80. PubMed ID: 11899152
[TBL] [Abstract][Full Text] [Related]
4. HLA class II immunogenetics of IDDM in Yemenite Jews.
Israel S; Kwon OJ; Weintrob N; Sprecher E; Bloch K; Assa S; Brautbar C; Vardi P
Hum Immunol; 1998 Nov; 59(11):728-33. PubMed ID: 9796741
[TBL] [Abstract][Full Text] [Related]
5. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).
Fernández O; R-Antigüedad A; Pinto-Medel MJ; Mendibe MM; Acosta N; Oliver B; Guerrero M; Papais-Alvarenga M; Fernández-Sánchez V; Leyva L
J Neurol; 2009 Dec; 256(12):1977-88. PubMed ID: 19585166
[TBL] [Abstract][Full Text] [Related]
6. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles.
Allen M; Sandberg-Wollheim M; Sjögren K; Erlich HA; Petterson U; Gyllensten U
Hum Immunol; 1994 Jan; 39(1):41-8. PubMed ID: 8181961
[TBL] [Abstract][Full Text] [Related]
7. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
[TBL] [Abstract][Full Text] [Related]
8. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A
Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330
[TBL] [Abstract][Full Text] [Related]
9. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations.
Trachtenberg EA; Yang H; Hayes E; Vinson M; Lin C; Targan SR; Tyan D; Erlich H; Rotter JI
Hum Immunol; 2000 Mar; 61(3):326-33. PubMed ID: 10689124
[TBL] [Abstract][Full Text] [Related]
10. Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility.
Tighe MR; Hall MA; Ashkenazi A; Siegler E; Lanchbury JS; Ciclitira PJ
Hum Immunol; 1993 Dec; 38(4):270-6. PubMed ID: 8138422
[TBL] [Abstract][Full Text] [Related]
11. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
12. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
Khankhanian P; Matsushita T; Madireddy L; Lizée A; Din L; Moré JM; Gourraud PA; Hauser SL; Baranzini SE; Oksenberg JR
BMC Med Genet; 2015 Jul; 16():55. PubMed ID: 26212423
[TBL] [Abstract][Full Text] [Related]
13. Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients.
Ciusani E; Allen M; Sandberg-Wollheim M; Eoli M; Salmaggi A; Milanese C; Nespolo A; Gyllensten U
Eur J Immunogenet; 1995 Apr; 22(2):171-8. PubMed ID: 7605774
[TBL] [Abstract][Full Text] [Related]
14. HLA associations in clozapine-induced agranulocytosis.
Yunis JJ; Corzo D; Salazar M; Lieberman JA; Howard A; Yunis EJ
Blood; 1995 Aug; 86(3):1177-83. PubMed ID: 7620171
[TBL] [Abstract][Full Text] [Related]
15. [HLA-DRB1/DQA1/DQB1 alleles and haplotypes in Czech children with celiac sprue].
Kotalová R; Vraná M; Dobrovolná M; Nevoral J; Loudová M
Cas Lek Cesk; 2002 Aug; 141(16):518-22. PubMed ID: 12404952
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
17. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.
Zavaglia C; Martinetti M; Silini E; Bottelli R; Daielli C; Asti M; Airoldi A; Salvaneschi L; Mondelli MU; Ideo G
J Hepatol; 1998 Jan; 28(1):1-7. PubMed ID: 9537846
[TBL] [Abstract][Full Text] [Related]
18. Type 1 diabetes in Jewish Ethiopian immigrants in Israel: HLA class II immunogenetics and contribution of new environment.
Zung A; Elizur M; Weintrob N; Bistritzer T; Hanukoglu A; Zadik Z; Phillip M; Miller K; Koren I; Brautbar C; Israel S
Hum Immunol; 2004 Dec; 65(12):1463-8. PubMed ID: 15603874
[TBL] [Abstract][Full Text] [Related]
19. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel.
Benedek G; Paperna T; Avidan N; Lejbkowicz I; Oksenberg JR; Wang J; Brautbar C; Israel S; Miller A;
Genes Immun; 2010 Jul; 11(5):423-31. PubMed ID: 20463743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
